Decision on EU marketing authorisation for this population expected by September 2024
Access to breast milk for sick newborns admitted in intensive care units plays a lifesaving role
A one-time dose of DURVEQTIX has reduced bleeds post-treatment compared to standard of care with a median annualized bleed rate (ABR) of zero bleeds (range 0 to 9.9)
Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis software
The pooled prevalence of GERD in the Indian population is 15.6 %
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
Selexipag is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
Sacubitril and Valsartan combination is used to treat chronic heart failure in adults
Subscribe To Our Newsletter & Stay Updated
